Technvision Ventures Ltd. has announced that its affiliate Solix Technologies has expanded its global leadership team with four strategic executive appointments, reinforcing the company's commitment to helping enterprises modernize their data infrastructure and accelerate AI-driven innovation.

Strategic Leadership Appointments

Solix Technologies has made four key appointments to strengthen its global operations and customer engagement capabilities. The new leadership team includes Bryan Powell as Senior Vice President of Professional Services, David Zuccolotto's promotion to Global Vice President of Sales, Matthew Long as Vice President of Sales for Europe, and Bob Wright as Vice President of Sales for Canada.

According to Sai Gundavelli, Founder and CEO of Solix Technologies, these appointments significantly strengthen the company's ability to help organizations modernize their data infrastructure, reduce legacy data risk, and accelerate AI-driven innovation.

Professional Services Leadership Enhancement

Bryan Powell joins Solix Technologies as Senior Vice President of Professional Services, bringing more than 20 years of global enterprise services leadership experience across SaaS, AI, cybersecurity, and data platforms. Powell will lead global delivery strategy, implementation excellence, and customer lifecycle value creation to ensure accelerated time-to-value for Solix customers.

Powell has held senior leadership roles at major technology companies including IBM, Cloudera, and Teradata, where he built and scaled global professional services organizations supporting Fortune 1000 enterprises. He holds a Master of Arts in Leadership and Administration from the University of Colorado and a Bachelor of Science degree from Colorado State University.

Global Sales Strategy Expansion

David Zuccolotto has been promoted to Global Vice President of Sales, recognizing his leadership and strategic impact in driving enterprise growth initiatives. With nearly 30 years of experience as a seasoned entrepreneur and enterprise technology executive, Zuccolotto will lead Solix's international sales strategy and strengthen key enterprise partnerships.

In his expanded global role, Zuccolotto will focus on driving adoption of the company's Enterprise AI and Information Architecture platforms, working closely with CIOs, CDOs, and enterprise architecture leaders to help organizations streamline data workflows and accelerate AI-powered transformation.

Regional Market Development

Matthew Long joins as Vice President of Sales for Europe, bringing more than 15 years of enterprise technology leadership and sales experience. Prior to joining Solix, Long served as Head of Modern Workspace at CDW, where he led digital workplace and cloud transformation initiatives for enterprise customers across the United Kingdom during his nearly 17-year career at the company.

Bob Wright has been appointed Vice President of Sales for Canada, contributing more than 25 years of enterprise technology leadership experience. Wright has worked with industry-leading technology companies including OpenText, Citrix, McAfee, Symantec, and Softchoice. Prior to joining Solix, he served as Senior Director at Messaging Architects, leading strategic initiatives focused on infrastructure modernization and regulatory compliance.

Company Background and Strategic Focus

Solix Technologies specializes in enterprise data management, information lifecycle governance, and AI-ready data platforms. The company's Common Data Platform and Enterprise AI solutions provide intelligent data classification, comprehensive governance, and semantic layers that create foundations for production-ready AI systems.

Technvision Ventures Limited positions itself as a pioneer in creating next-generation enterprise software businesses, innovating and incubating new ideas in emerging technology areas. The company serves as the parent organization for Solix Technologies Inc., supporting its mission to help enterprises become AI-native while maintaining compliance with emerging AI regulations across various industries including healthcare, pharmaceutical, financial services, retail, and manufacturing sectors.

Technvision Ventures Ltd announced its unaudited financial results for the third quarter and nine months ended December 31, 2025, following a Board of Directors meeting held on February 13, 2026. The company submitted its quarterly results under Regulation 33 of SEBI (LODR) Regulations, 2015, with both standalone and consolidated financial statements reviewed by independent auditors.

Financial Performance Overview

The company's financial results for Q3FY26 present a mixed performance scenario across different operational metrics:

Segment-wise Revenue Analysis

The company's revenue distribution shows significant dependence on overseas operations, with domestic business contributing minimally to overall performance:

Expense Structure and Profitability

Employee benefits expense constituted the largest component of operational costs, representing ₹455.95 lakhs on standalone basis and ₹1,432.62 lakhs on consolidated basis for Q3FY26. Other significant expenses included finance costs of ₹44.69 lakhs (standalone) and other expenses totaling ₹82.48 lakhs (standalone) for the quarter.

Nine-Month Performance Indicators

For the nine months ended December 31, 2025, the company reported total income of ₹1,854.32 lakhs on standalone basis and ₹20,338.33 lakhs on consolidated basis. The nine-month period showed total expenses of ₹1,750.95 lakhs (standalone) and ₹19,765.53 lakhs (consolidated).

Board Decisions and Regulatory Compliance

The Board meeting, conducted from 3:35 PM to 4:35 PM on February 13, 2026, approved the unaudited financial results along with Independent Auditors' Limited Review Reports. Additionally, the board revised the remuneration for Mrs. Geetanjali Toopran, Whole Time Director and CFO, subject to member approval. The company maintains compliance with BSE requirements under scrip code 501421, with all documentation digitally signed and submitted to the Corporate Relationship Department.